Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Transactions
Holdings
Ownership
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other


Tags
Accel. buyback
Quarterly results
Auditor change

AbbVie Inc. (ABBV) Create: Alert

All | News | Filings
Date FiledTypeDescription
10/12/2023 8-K Quarterly results
10/04/2023 8-K Results of Operations and Financial Condition, Financial Statements and Exhibits  Interactive Data
Docs: "AbbVie Inc. Guidance Including the Impact of Acquired IPR&D and Milestones Expense"
10/03/2023 4 Alpern Robert J (Director) has filed a Form 4 on AbbVie Inc.
Txns: Granted 50 options to buy @ $149.06, valued at $7.5k
10/03/2023 4 RAPP EDWARD J (Director) has filed a Form 4 on AbbVie Inc.
Txns: Granted 259 options to buy @ $149.06, valued at $38.6k
09/27/2023 4 GONZALEZ RICHARD A (CHAIRMAN OF THE BOARD AND CEO) has filed a Form 4 on AbbVie Inc.
Txns: Gifted 42,000 shares @ $0
08/07/2023 10-Q Quarterly Report for the period ended June 30, 2023
08/02/2023 4 GONZALEZ RICHARD A (CHAIRMAN OF THE BOARD AND CEO) has filed a Form 4 on AbbVie Inc.
Txns: Sold 18,500 shares @ $149.15, valued at $2.8M
Sold 60,000 shares @ $148.58, valued at $8.9M
07/31/2023 144 Form 144 - Report of proposed sale of securities:
07/31/2023 144 Form 144 - Report of proposed sale of securities:
07/27/2023 8-K Quarterly results
Docs: "AbbVie Reports Second-Quarter 2023 Financial Results"
07/25/2023 144 Form 144 - Report of proposed sale of securities:
07/10/2023 3 Donoghoe Nicholas (EVP, Chief Bus/Strat Officer) has filed a Form 3 on AbbVie Inc.
07/06/2023 8-K Results of Operations and Financial Condition, Financial Statements and Exhibits  Interactive Data
Docs: "AbbVie Inc. Guidance Including the Impact of Acquired IPR&D and Milestones Expense"
07/05/2023 4 RAPP EDWARD J (Director) has filed a Form 4 on AbbVie Inc.
Txns: Granted 287 options to buy @ $134.73, valued at $38.7k
07/05/2023 4 Alpern Robert J (Director) has filed a Form 4 on AbbVie Inc.
Txns: Granted 55 options to buy @ $134.73, valued at $7.4k
06/29/2023 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
06/28/2023 11-K Form 11-K - Annual report of employee stock purchase, savings and similar plans:
06/09/2023 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
05/31/2023 SD Form SD - Specialized disclosure report:
05/12/2023 4 Strom Carrie C (SVP & PRES GLOBAL ALLERG AESTH) has filed a Form 4 on AbbVie Inc.
Txns: Paid exercise price by delivering 2,876 shares @ $146.42, valued at $421.1k
05/10/2023 8-K Submission of Matters to a Vote of Security Holders  Interactive Data
05/09/2023 4 WADDELL FREDERICK H (Director) has filed a Form 4 on AbbVie Inc.
Txns: Granted 1,450 shares @ $0
05/09/2023 4 TILTON GLENN F (Director) has filed a Form 4 on AbbVie Inc.
Txns: Granted 1,450 shares @ $0
05/09/2023 4 Roberts Rebecca B (Director) has filed a Form 4 on AbbVie Inc.
Txns: Granted 1,450 shares @ $0
05/09/2023 4 RAPP EDWARD J (Director) has filed a Form 4 on AbbVie Inc.
Txns: Granted 1,450 shares @ $0
05/09/2023 4 MEYER MELODY B (Director) has filed a Form 4 on AbbVie Inc.
Txns: Granted 1,450 shares @ $0
05/09/2023 4 Hart Brett J (Director) has filed a Form 4 on AbbVie Inc.
Txns: Granted 1,450 shares @ $0
05/09/2023 4 AUSTIN ROXANNE S (Director) has filed a Form 4 on AbbVie Inc.
Txns: Granted 1,450 shares @ $0
05/09/2023 4/A AUSTIN ROXANNE S (Director) has filed a Form 4 on AbbVie Inc.
Txns: Sold 6,222 shares @ $150.5, valued at $936.4k
05/09/2023 4 BURNSIDE WILLIAM H.L. (Director) has filed a Form 4 on AbbVie Inc.
Txns: Granted 1,450 shares @ $0
05/09/2023 4 FREYMAN THOMAS C (Director) has filed a Form 4 on AbbVie Inc.
Txns: Granted 1,450 shares @ $0
05/09/2023 4 Alpern Robert J (Director) has filed a Form 4 on AbbVie Inc.
Txns: Granted 1,450 shares @ $0
05/05/2023 10-Q Quarterly Report for the period ended March 31, 2023
05/04/2023 PX14A6G Form PX14A6G - Notice of exempt solicitation submitted by non-management:
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy